Clinical Trial Update: Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing procarbazine with isotretinoin for recurrent primary malignant gliomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Malignant Glioma

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• Procarbazine (procarbazine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 3 | Status: WITHDRAWN